CORD-19:932bcdd2f6c6d487386e8bf983e4874387771be1 / 11043-11126 JSONTXT

{"target":"https://pubannotation.org/docs/sourcedb/CORD-19/sourceid/932bcdd2f6c6d487386e8bf983e4874387771be1","sourcedb":"CORD-19","sourceid":"932bcdd2f6c6d487386e8bf983e4874387771be1","text":"Regulatory T cells: a privileged target for the treatment of autoimmune diseases L.","tracks":[{"project":"CORD-19-Sentences","denotations":[{"id":"TextSentencer_T79","span":{"begin":0,"end":83},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"attributes":[{"subj":"TextSentencer_T79","pred":"source","obj":"CORD-19-Sentences"}]},{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T79","span":{"begin":0,"end":83},"obj":"Sentence"}],"attributes":[{"subj":"T79","pred":"source","obj":"CORD-19_Custom_license_subset"}]},{"project":"CORD-19-PD-HP","denotations":[{"id":"T85243","span":{"begin":61,"end":80},"obj":"Phenotype"}],"attributes":[{"id":"A96294","pred":"hp_id","subj":"T85243","obj":"http://purl.obolibrary.org/obo/HP_0002960"},{"subj":"T85243","pred":"source","obj":"CORD-19-PD-HP"}]},{"project":"CORD-19-PD-MONDO","denotations":[{"id":"T65807","span":{"begin":61,"end":80},"obj":"Disease"},{"id":"T86285","span":{"begin":61,"end":80},"obj":"Disease"}],"attributes":[{"id":"A570","pred":"mondo_id","subj":"T65807","obj":"http://purl.obolibrary.org/obo/MONDO_0007179"},{"id":"A85821","pred":"mondo_id","subj":"T86285","obj":"http://purl.obolibrary.org/obo/MONDO_0007179"},{"subj":"T65807","pred":"source","obj":"CORD-19-PD-MONDO"},{"subj":"T86285","pred":"source","obj":"CORD-19-PD-MONDO"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"CORD-19-Sentences","color":"#ecd693","default":true},{"id":"CORD-19_Custom_license_subset","color":"#bc93ec"},{"id":"CORD-19-PD-HP","color":"#93eca2"},{"id":"CORD-19-PD-MONDO","color":"#ec939d"}]}]}}